Last reviewed · How we verify
Intra-abdominal infections
Approved treatments
- Piperacillin And Tazobactam · Pfizer
Piperacillin and tazobactam is an antibacterial drug combining a penicillin with a beta-lactamase inhibitor.
Clinical guidelines
- FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of postpartum endometritis or pelvic inflammatory disease in adults caused by beta-lactamase producing isolates of Escherichia coli. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of intra-abdominal infections in adults and pediatric patients (2 months of age and older) caused by beta-lactamase producing isolates of Escherichia coli or members of the Bacteroides fragilis group. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of nosocomial pneumonia (moderate to severe) in adults and pediatric patients (2 months of age and older) caused by beta-lactamase producing isolates of Staphylococcus aureus and by piperacillin and tazobactam-susceptible Acinetobacter baumannii, Haemophilus influenzae, Klebsiella pneumoniae, and Pseudomonas aeruginosa (Nosocomial pneumonia caused by P. aeruginosa should be treated in combination with an aminoglycoside). - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of uncomplicated and complicated skin and skin structure infections in adults, including cellulitis, cutaneous abscesses, and ischemic/diabetic foot infections caused by beta-lactamase producing isolates of Staphylococcus aureus. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of community-acquired pneumonia (moderate severity only) in adults caused by beta-lactamase producing isolates of Haemophilus influenzae. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of intra-abdominal infections in adults and pediatric patients (2 months of age and older) caused by beta-lactamase producing isolates of Escherichia coli or members of the Bacteroides fragilis group. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of nosocomial pneumonia (moderate to severe) in adults and pediatric patients (2 months of age and older) caused by beta-lactamase producing isolates of Staphylococcus aureus and piperacillin and tazobactam-susceptible Acinetobacter baumannii, Haemophilus influenzae, Klebsiella pneumoniae, and Pseudomonas aeruginosa. Nosocomial pneumonia caused by P. aeruginosa should be treated in combination with an aminoglycoside. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of uncomplicated and complicated skin and skin structure infections, including cellulitis, cutaneous abscesses, and ischemic/diabetic foot infections in adults caused by beta-lactamase producing isolates of Staphylococcus aureus. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of postpartum endometritis or pelvic inflammatory disease in adults caused by beta-lactamase producing isolates of Escherichia coli. - FDA label — 1L
Piperacillin and tazobactam is indicated for the treatment of community-acquired pneumonia (moderate severity only) in adults caused by beta-lactamase producing isolates of Haemophilus influenzae.
Competitive intelligence
For the full treatment-landscape CI brief — marketed leaders side-by-side, pipeline by phase, recent regulatory actions, sponsor landscape:
- Intra-abdominal infections patent landscape — cliff calendar, originator estates, attackable patents
- Intra-abdominal infections treatment landscape brief
- Intra-abdominal infections treatment updates RSS
Frequently asked questions about Intra-abdominal infections
What drugs treat Intra-abdominal infections?
Tracked treatments include Piperacillin And Tazobactam.
What is the treatment for Intra-abdominal infections?
Standard treatment for Intra-abdominal infections includes Piperacillin And Tazobactam. See the treatment landscape page for first-line, second-line and salvage options.
What are the treatment guidelines for Intra-abdominal infections?
FDA label publishes guidelines for Intra-abdominal infections. 10 guideline references tracked.
Related
- Treatment landscape: Intra-abdominal infections patent cliff · Intra-abdominal infections CI report
- Treatment: Piperacillin And Tazobactam · Pfizer
- All diseases: Browse the disease index · Disease landscape hub
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing